Key Takeaways
- • Hong Kong Stock Exchange IPO market surged dramatically in H1 2026, with 87 new listings (98% YoY increase) and HK$210.2 billion in fundraising (92% YoY increase), nearly matching historical peak levels achieved in 2020 when HKEX was the world's second-largest IPO market.
- • HKEX processed 534 active listing applications by end of June 2026, with 35 enterprises completing debuts in a single three-week period, signaling sustained investor appetite for Hong Kong listings after a severe contraction in 2023 (HK$46 billion in annual fundraising).
- • The recovery represents a structural turnaround driven by Hong Kong's economic stimulus policies and strategic positioning to capitalize on regional transformation, reversing a multi-year decline that had made the exchange a less attractive destination for capital-raising.
- • Chinese stocks, including 36Kr (KRKR), demonstrated significant pre-market volatility in early September 2026, with KRKR shares gaining over 5% in U.S. pre-market trading, reflecting broader investor appetite for Chinese equities amid market sentiment shifts.
Summary
Hong Kong's primary market experienced a dramatic resurgence in the first half of 2026, marking a historic reversal from years of structural decline. The Hong Kong Stock Exchange recorded 87 new listings—a 98% year-on-year increase—with total IPO fundraising reaching HK$210.2 billion, representing a 92% surge compared to the prior year period. This performance nearly matched the exchange's historical peak, demonstrating the vigor of capital-raising activity in the region.
The scale of activity was visually and operationally unprecedented. On June 26 alone, HKEX rang the listing bell six times in a single day, drawing record crowds to the listing hall. HKEX Chairman Timothy Freshwater noted the exceptional nature of the moment, remarking that he had never witnessed such congestion at the venue. By month-end, the exchange maintained 534 active listing applications under processing, with approximately 35 enterprises completing their market debuts within a concentrated three-week window.
The recovery is particularly significant when contextualized against the exchange's recent history. In 2023, HKEX's annual fundraising had collapsed to approximately HK$46 billion, a level that discouraged most prospective issuers. This represented a severe contraction from 2020, when Hong Kong commanded roughly HK$400 billion in IPO fundraising, positioning it as the world's second-largest IPO market after Nasdaq. The 2026 recovery suggests a structural inflection point rather than cyclical relief.
Analysts attribute the turnaround to Hong Kong's deliberate economic stimulus initiatives and strategic repositioning to capitalize on broader regional transformation. The sustained pipeline of candidates awaiting listing consideration indicates this momentum may extend beyond H1 2026. For institutional investors and fund managers, the renewal of Hong Kong's primary market presents renewed opportunities for IPO allocation and emerging-market exposure in the Asian capital-raising landscape.
The scale of activity was visually and operationally unprecedented. On June 26 alone, HKEX rang the listing bell six times in a single day, drawing record crowds to the listing hall. HKEX Chairman Timothy Freshwater noted the exceptional nature of the moment, remarking that he had never witnessed such congestion at the venue. By month-end, the exchange maintained 534 active listing applications under processing, with approximately 35 enterprises completing their market debuts within a concentrated three-week window.
The recovery is particularly significant when contextualized against the exchange's recent history. In 2023, HKEX's annual fundraising had collapsed to approximately HK$46 billion, a level that discouraged most prospective issuers. This represented a severe contraction from 2020, when Hong Kong commanded roughly HK$400 billion in IPO fundraising, positioning it as the world's second-largest IPO market after Nasdaq. The 2026 recovery suggests a structural inflection point rather than cyclical relief.
Analysts attribute the turnaround to Hong Kong's deliberate economic stimulus initiatives and strategic repositioning to capitalize on broader regional transformation. The sustained pipeline of candidates awaiting listing consideration indicates this momentum may extend beyond H1 2026. For institutional investors and fund managers, the renewal of Hong Kong's primary market presents renewed opportunities for IPO allocation and emerging-market exposure in the Asian capital-raising landscape.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.